Minnesota IRB Approval 2009

From:
Date: Thu, 27 Aug 2009 23:10:50 -0500 (CDT)
To: Aaron Folsom
Subject: 8412M01053 - PI Folsom - IRB - APVD Continuing Review
The IRB: Human Subjects Committee renewed its approval of the referenced
study listed below:
Study Number: 8412M01053
Principal Investigator: Aaron Folsom
Expiration Date: 08/25/2010
Approval Date: 08/26/2009
Title(s):
Atherosclerosis Risk in Communities Study
________________________________________________________
This e-mail confirmation is your official University of Minnesota RSPP
notification of continuing review approval. You will not receive a hard copy
or letter.
This secure electronic notification between password protected
authentications has been deemed by the University of Minnesota to constitute
a legal signature.
You may go to the View Completed section of http://eresearch.umn.edu/ to
view or print your continuing review submission.
For grant certification purposes you will need this date and the Assurance
of Compliance number, which is FWA00000312 (Fairview Health Systems Research
FWA00000325, Gillette Childrens Specialty Healthcare FWA00004003). Approval
will expire one year from that date. You will receive a report form two
months before the expiration date.
In the event that you submitted a consent document with the continuing
review form, it has also been reviewed and approved. If you provided a
summary of subjects' experience to include non-UPIRTSO events, these are
hereby acknowledged.
As Principal Investigator of this project, you are required by federal
regulations to inform the IRB of any proposed changes in your research that
will affect human subjects. Changes should not be initiated until written
IRB approval is received. Unanticipated problems and adverse events should
be reported to the IRB as they occur. Research projects are subject to
continuing review.
If you have any questions, please call the IRB office at (612) 626-5654.
The IRB wishes you continuing success with your research.